Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches.
Crellastatin A, a cytotoxic sulfated bis-steroid isolated from the Vanuatu Island marine sponge Crella sp., has been selected as an interesting probe for a comprehensive proteomic analysis, directed to the characterization of its protein interactors. Since its peculiar structural features, crellastatin A has been submitted to a mass spectrometry-based DARTS (Drug Affinity Responsive Target Stability) approach combined with t-LiP MRM (targeted-Limited Proteolysis-Multiple Reaction Monitoring), rather than a classical Affinity Purification strategy. PARP-1 (Poly-ADP-ribose-polymerase-1) emerged as the main crellastatin A cellular partner. This result has been confirmed by both biochemical and in silico analyses. Further in vitro biological assays highlighted an interesting crellastatin A inhibitory activity on PARP-1.